Tag Archives: Patients

FDA Approves Kerendia (finerenone) for the Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

FDA Approves Kerendia (finerenone) for the Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes WHIPPANY, N.J.– July 9, 2021 (BUSINESS WIRE)– Bayer announced today the United States (U.S.) Food and Drug Administration (FDA) has approved Kerendia (finerenone), a first-in-class nonsteroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of sustained… Read More »

Roundup: New telehealth app for COVID-19 patients in India, Japanese firms’ initiative for brain health and more briefs

Indian telehealth app offers COVID-19 virtual consultations Indian digital health startup 5e Healthcare is now offering virtual consultations for COVID-19 patients through its mobile app. Its 5eCare app assists both asymptomatic and suspected COVID-19 patients in accessing remote care within 15 minutes of booking. Attending doctors are giving out digital prescriptions to their patients through… Read More »

Spending on Medicines In and Post-COVID Say a Lot About Patients and Larger Healthcare Trends – an IQVIA Update

Spending on medicines, globally, will rebound this year and rise above pre-pandemic levels through 2025. Between 2021 and 2025, the annual growth global growth rate for prescription drugs spending is expected to range from 3% to 6%, a $ 1.6 trillion bill for the worlds’s total Rx medicines market. That relatively low single-digit growth rate… Read More »

Vaccines Won’t Protect Millions of Patients With Weakened Immune Systems

The Coronavirus Outbreak liveLatest Updates Maps and Cases Pause on Johnson & Johnson Vaccine Risk Near You Who Can Get Vaccinated? Advertisement Continue reading the main story Supported by Continue reading the main story Vaccines Won’t Protect Millions of Patients With Weakened Immune Systems Many cannot produce enough infection-fighting cells to fend off the coronavirus.… Read More »